AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23819659 — intervention group
Group type: EXPERIMENTAL
Intervention: methylprednisolone 80 mg + 5 mL of levobupivacaine without epinephrine + 3 mL of 0.9% saline solution
Number of subjects: 60
Study 23819659 — intervention group
Group type: COMPARATOR
Intervention: methylprednisolone 80 mg + 8 mL of 0.9% saline solution
Number of subjects: 60
Study 21174634 — intervention group
Group type: EXPERIMENTAL
Intervention: Body weight support treadmill training (BWSTT) without additional therapist or self-support of the upper limbs
Number of subjects: 17
Study 21174634 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait training conditions requiring self-support of the upper limbs
Number of subjects: 17
Study 21174634 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants holding on to a stable handrail during gait training
Number of subjects: 17
Study 21174634 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable upper-limb support during gait training
Number of subjects: 17
Study 18378926 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic simulator training on a bench-top knee simulator
Number of subjects: 20
Study 18378926 — intervention group
Group type: COMPARATOR
Intervention: No additional training (Control)
Number of subjects: 20
Study 16015691 — intervention group
Group type: EXPERIMENTAL
Intervention: Itopride 150 mg t.i.d.
Number of subjects: 26
Study 16015691 — intervention group
Group type: EXPERIMENTAL
Intervention: Itopride 300 mg t.i.d.
Number of subjects: 26
Study 16015691 — intervention group
Group type: EXPERIMENTAL
Intervention: Itopride 100 mg t.i.d.
Number of subjects: 26
Study 12858319 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch
Number of subjects: 48
Study 12858319 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 48
Study 10542821 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic activity group
Number of subjects: 174
Study 10542821 — intervention group
Group type: COMPARATOR
Intervention: Stretching and toning group
Number of subjects: 174
Study 8897082 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol (50 micrograms b.i.d., at 10 and 22 hr)
Number of subjects: 0
Study 1853170 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethizole for 3 days
Number of subjects: 264
Study 1853170 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethizole for 10 days
Number of subjects: 264
Study 1853170 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivmecillinam for 3 days
Number of subjects: 264
Study 1853170 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 264
Study 1853170 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethizole treated groups
Number of subjects: 264
Study 1853170 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivmecillinam treated group
Number of subjects: 264
Study 6401908 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (40 to 80 mg 4 times a day)
Number of subjects: 23
Study 6401908 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol (5 to 10 mg 2 times a day)
Number of subjects: 23
Study 6401908 — intervention group
Group type: COMPARATOR
Intervention: Control period
Number of subjects: 23
Study 6401908 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol and Pindolol (both)
Number of subjects: 23
Study 31500602 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored and therapeutically guided internet-based intervention (IMI) program consisting of six guided IMIs (6-8 modules, duration: 6-8 weeks) targeting different symptoms.
Number of subjects: 360
Study 31500602 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment as usual (TAU+)
Number of subjects: 360
Study 29573460 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor self-rated oral health in older age group
Number of subjects: 0
Study 29573460 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor self-rated oral health in Guarani peoples
Number of subjects: 0
Study 29573460 — intervention group
Group type: EXPERIMENTAL
Intervention: Fewer functional teeth
Number of subjects: 0
Study 29573460 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 or more untreated decayed teeth
Number of subjects: 0
Study 29573460 — intervention group
Group type: EXPERIMENTAL
Intervention: Normative need for extraction
Number of subjects: 0
Study 29573460 — intervention group
Group type: EXPERIMENTAL
Intervention: Normative need for restoration of one or more surfaces
Number of subjects: 0
Study 29573460 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothache
Number of subjects: 0
Study 29573460 — intervention group
Group type: EXPERIMENTAL
Intervention: Difficulty speaking due to dental problems
Number of subjects: 0
Study 27114074 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide/dexamethasone plus high-dose chemotherapy and autologous stem cell transplantation followed by lenalidomide maintenance
Number of subjects: 282
Study 27114074 — intervention group
Group type: COMPARATOR
Intervention: Lenalidomide/dexamethasone
Number of subjects: 282
Study 25323254 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental stress tasks
Number of subjects: 310
Study 25323254 — intervention group
Group type: COMPARATOR
Intervention: Platelet aggregation responses to serotonin and epinephrine at rest
Number of subjects: 310
Study 22837319 — intervention group
Group type: EXPERIMENTAL
Intervention: MLVA typing
Number of subjects: 1682
Study 22837319 — intervention group
Group type: COMPARATOR
Intervention: PCR ribotyping
Number of subjects: 1682
Study 20658205 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency portacaval shunt
Number of subjects: 211
Study 20658205 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic sclerotherapy followed by rescue portacaval shunt
Number of subjects: 211
Study 19124377 — intervention group
Group type: EXPERIMENTAL
Intervention: Erdosteine 300 mg
Number of subjects: 30
Study 19124377 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine 600 mg
Number of subjects: 30
Study 19124377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 15755632 — intervention group
Group type: EXPERIMENTAL
Intervention: OncoVAX therapy (active specific immunotherapy using autologous tumor cells with BCG vaccine)
Number of subjects: 0
Study 15755632 — intervention group
Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 0
Study 15755632 — intervention group
Group type: EXPERIMENTAL
Intervention: OncoVAX therapy
Number of subjects: 0
Study 12464756 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational nursing intervention based on the Progressively Lowered Stress Threshold model
Number of subjects: 237
Study 12464756 — intervention group
Group type: COMPARATOR
Intervention: Routine information and referrals for case management, community‐based services, and support groups
Number of subjects: 237
Study 10921218 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme and radiotherapy
Number of subjects: 50
Study 10921218 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 50
Study 8748726 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized immunotherapy (IT) (Alpare)
Number of subjects: 23
Study 8748726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 1697057 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 week multidisciplinary inpatient pain management programme
Number of subjects: 0
Study 1697057 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 week multidisciplinary outpatient programme
Number of subjects: 0
Study 1697057 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 7318354 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal dilation (PTD) for FMD
Number of subjects: 30
Study 7318354 — intervention group
Group type: COMPARATOR
Intervention: Surgery for FMD
Number of subjects: 30
Study 7318354 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal dilation (PTD) for atherosclerosis
Number of subjects: 30
Study 7318354 — intervention group
Group type: COMPARATOR
Intervention: Surgery for atherosclerosis
Number of subjects: 30
Study 30256303 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal harness attachment
Number of subjects: 0
Study 30256303 — intervention group
Group type: COMPARATOR
Intervention: Frontal harness attachment
Number of subjects: 0
Study 29097450 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI plus MT
Number of subjects: 888
Study 29097450 — intervention group
Group type: COMPARATOR
Intervention: MT alone
Number of subjects: 888
Study 29097450 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI compared with MT
Number of subjects: 888
Study 27217544 — intervention group
Group type: EXPERIMENTAL
Intervention: >5% weight gain
Number of subjects: 2301
Study 24650024 — intervention group
Group type: EXPERIMENTAL
Intervention: ABG‐I anatomical stem
Number of subjects: 100
Study 24650024 — intervention group
Group type: COMPARATOR
Intervention: Unique femoral stem
Number of subjects: 100
Study 22201324 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized prolate ablation (OPA)
Number of subjects: 40
Study 22201324 — intervention group
Group type: COMPARATOR
Intervention: Optimized aspheric treatment zone ablation (OATz)
Number of subjects: 40
Study 20398349 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised general exercise programme
Number of subjects: 60
Study 20398349 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized walking programme
Number of subjects: 60
Study 20398349 — intervention group
Group type: COMPARATOR
Intervention: Usual physiotherapy
Number of subjects: 60
Study 17976843 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator (ICD) therapy
Number of subjects: 0
Study 17976843 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT) with and without defibrillator back‐up
Number of subjects: 0
Study 17976843 — intervention group
Group type: COMPARATOR
Intervention: Subgroup analyses of prospective randomized ICD‐ and CRT‐intervention trials
Number of subjects: 0
Study 17976843 — intervention group
Group type: COMPARATOR
Intervention: Published cohort studies
Number of subjects: 0
Study 16448994 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 131
Study 16448994 — intervention group
Group type: COMPARATOR
Intervention: Fibrinolysis
Number of subjects: 131
Study 16448994 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG within the first 30 days
Number of subjects: 131
Study 16448994 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG after 30 days
Number of subjects: 131
Study 16448994 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG within the first year after STEMI
Number of subjects: 131
Study 16448994 — intervention group
Group type: EXPERIMENTAL
Intervention: Early CABG
Number of subjects: 131
Study 12008991 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group (n=54) attended two group nutrition education classes and one individual diet counseling session led by the same dietitian.
Number of subjects: 104
Study 12008991 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=50) received usual nonindividualized nutrition education from cardiac rehabilitation therapists.
Number of subjects: 104
Study 10321414 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan 600 mg once daily
Number of subjects: 243
Study 10321414 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study 8735463 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermal exposure to 86 mg/m3 cis-1,3-DCP for 45 minutes
Number of subjects: 5
Study 1767904 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam IV solution 10 mg
Number of subjects: 75
Study 1767904 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 75
Study 1767904 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 6412612 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil 0.75 mg
Number of subjects: 66
Study 6412612 — intervention group
Group type: COMPARATOR
Intervention: fentanyl 0.25 mg
Number of subjects: 66
Study 29545067 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab 300 mg intravenous every 4 weeks for 2 years
Number of subjects: 889
Study 29545067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 889
Study 29545067 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab (continuing patients)
Number of subjects: 889
Study 29545067 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab (naive patients)
Number of subjects: 889
Study 27253526 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan diet (excluding animal-based food including fish)
Number of subjects: 93
Study 27253526 — intervention group
Group type: COMPARATOR
Intervention: Conventional diabetic diet recommended by the Korean Diabetes Association 2011
Number of subjects: 93
Study 25712913 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrating Homologous Samples (IHS)
Number of subjects: 0
Study 25712913 — intervention group
Group type: COMPARATOR
Intervention: Randomly Dividing Homologous Samples (RDHS)
Number of subjects: 0
Study 25712913 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrating Homologous Samples (IHS) with feature selection
Number of subjects: 0
Study 23203322 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (LNG-IUS)
Number of subjects: 90
Study 23203322 — intervention group
Group type: COMPARATOR
Intervention: Medroxyprogesterone acetate (MPA, 10 mg/d for 10 days per cycle)
Number of subjects: 90
Study 23203322 — intervention group
Group type: COMPARATOR
Intervention: Norethisterone (NET, 15 mg/d for 10 days per cycle)
Number of subjects: 90
Study 20194584 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training
Number of subjects: 31
Study 20194584 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 31
Study 19008622 — intervention group
Group type: EXPERIMENTAL
Intervention: Acidic center-filled chewing gum (pure, 4X/day)
Number of subjects: 80
Study 19008622 — intervention group
Group type: EXPERIMENTAL
Intervention: Acidic center-filled chewing gum (diluted, 4X/day)
Number of subjects: 80
Study 16469126 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized unit (C-U)
Number of subjects: 160
Study 16469126 — intervention group
Group type: COMPARATOR
Intervention: Paper-based unit (PB-U)
Number of subjects: 160
Study 14623537 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg)
Number of subjects: 9366
Study 14623537 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (20 mg)
Number of subjects: 9366
Study 14623537 — intervention group
Group type: COMPARATOR
Intervention: Combination treatment (anastrozole + tamoxifen)
Number of subjects: 9366
Study 10928757 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin drops (one drop every night for one week, then one drop once a week for one month)
Number of subjects: 19
Study 10928757 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacitracin ointment (or erythromycin/gentamicin if resistant to bacitracin) applied to the lid margin
Number of subjects: 19
Study 10928757 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 volunteers, 30 lids)
Number of subjects: 19
Study 8922762 — intervention group
Group type: EXPERIMENTAL
Intervention: Humidified isoflurane
Number of subjects: 59
Study 8922762 — intervention group
Group type: COMPARATOR
Intervention: Non-humidified isoflurane
Number of subjects: 59
Study 1279571 — intervention group
Group type: COMPARATOR
Intervention: DDD pacing mode
Number of subjects: 16
Study 1279571 — intervention group
Group type: COMPARATOR
Intervention: VVIR pacing mode
Number of subjects: 16
Study 1279571 — intervention group
Group type: EXPERIMENTAL
Intervention: DDDR pacing mode
Number of subjects: 16
Study 1279571 — intervention group
Group type: EXPERIMENTAL
Intervention: DDDR pacing mode in patients with isolated sinus node disease (n = 9)
Number of subjects: 16
Study 1279571 — intervention group
Group type: COMPARATOR
Intervention: DDDR pacing mode in patients with intermittent second or third degree AV block (n = 7)
Number of subjects: 16
Study 3894250 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol (100 mg intravenous perfusion over 24 hr or 600 mg orally, followed by 1200 mg/day orally)
Number of subjects: 71
Study 3894250 — intervention group
Group type: COMPARATOR
Intervention: Control (no acebutolol)
Number of subjects: 71
Study 3894250 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol and Control
Number of subjects: 71
Study 29148629 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth rinse with carbohydrate solution (MRCS)
Number of subjects: 21
Study 29148629 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 29148629 — intervention group
Group type: COMPARATOR
Intervention: Control (no mouth rinse)
Number of subjects: 21
Study 30227642 — intervention group
Group type: EXPERIMENTAL
Intervention: Game-Based Learning (GBL)
Number of subjects: 120
Study 30227642 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification
Number of subjects: 120
Study 30227642 — intervention group
Group type: COMPARATOR
Intervention: Control (Traditional Teaching Method)
Number of subjects: 120
Study 30227642 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (GBL and Gamification vs Control)
Number of subjects: 120
Study 25545313 — intervention group
Group type: EXPERIMENTAL
Intervention: Deproteinized bovine bone (DBB) graft
Number of subjects: 20
Study 25545313 — intervention group
Group type: COMPARATOR
Intervention: Control group (no graft)
Number of subjects: 20
Study 25545313 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups over time
Number of subjects: 20
Study 25500201 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based prevention program 'Paesaggi di Prevenzione'
Number of subjects: 7652
Study 22622138 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline PIIINP levels <0.72 U/mL
Number of subjects: 142
Study 22622138 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline PIIINP levels >0.72 U/mL
Number of subjects: 142
Study 22622138 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline PIIINP
Number of subjects: 142
Study 20860916 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of mycophenolate mofetil 500 mg (Suprimun®)
Number of subjects: 24
Study 20860916 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation of mycophenolate mofetil 500 mg
Number of subjects: 24
Study 19094408 — intervention group
Group type: EXPERIMENTAL
Intervention: Training designed to improve information management knowledge, skills, and use of Web-based resources.
Number of subjects: 0
Study 16687365 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecamylamine (6 mg/day)
Number of subjects: 35
Study 16687365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 11814370 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Buddy interactive device
Number of subjects: 134
Study 11814370 — intervention group
Group type: COMPARATOR
Intervention: Asthma diary
Number of subjects: 134
Study 10417456 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 20 microgram.kg‐1
Number of subjects: 120
Study 10417456 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 35 microgram.kg‐1
Number of subjects: 120
Study 10417456 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 50 microgram.kg‐1
Number of subjects: 120
Study 10417456 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine (35 or 50 microgram.kg‐1) with isoflurane discontinued
Number of subjects: 120
Study 10417456 — intervention group
Group type: COMPARATOR
Intervention: Atropine instead of glycopyrronium with neostigmine
Number of subjects: 120
Study 8770800 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) leg cycle ergometry training, 30-minute sessions, total of 24 sessions over 19 weeks.
Number of subjects: 8
Study 8770800 — intervention group
Group type: EXPERIMENTAL
Intervention: Submaximal NMES leg cycle exercise at an absolute work rate (0 W).
Number of subjects: 8
Study 2019078 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle biopsy
Number of subjects: 7
Study 2019078 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal exercise activities (lifters)
Number of subjects: 7
Study 2019078 — intervention group
Group type: EXPERIMENTAL
Intervention: Injury (runner)
Number of subjects: 7
Study 2019078 — intervention group
Group type: COMPARATOR
Intervention: Control week (non-active subjects and runners)
Number of subjects: 7
Study 2019078 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight training
Number of subjects: 7
Study 2019078 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscular injury
Number of subjects: 7
Study 2019078 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense weight-lifting session
Number of subjects: 7
Study 417671 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticarcillin (T)
Number of subjects: 253
Study 417671 — intervention group
Group type: COMPARATOR
Intervention: Carbenicillin (C)
Number of subjects: 253
Study 31597536 — intervention group
Group type: EXPERIMENTAL
Intervention: theory-based, data-driven, multimedia, simulated concussion reporting module
Number of subjects: 520
Study 31597536 — intervention group
Group type: COMPARATOR
Intervention: NCAA Concussion Fact Sheet
Number of subjects: 520
Study 31037806 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume resistance training (6 months, twice a week)
Number of subjects: 54
Study 31037806 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintained pharmacological treatments)
Number of subjects: 54
Study 28363197 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling
Number of subjects: 40
Study 28363197 — intervention group
Group type: EXPERIMENTAL
Intervention: Short message service (SMS)
Number of subjects: 40
Study 28363197 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study 25514098 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 0
Study 25514098 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Moderate-Intensity Exercise (CME)
Number of subjects: 0
Study 25514098 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 0
Study 25514098 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 0